Bleeding risk of acupuncture for patients with hematological malignancies accompanying thrombocytopenia: A retrospective chart review

Bleeding risk of acupuncture for patients with hematological malignancies accompanying thrombocytopenia: A retrospective chart review - Bleeding risk of acupuncture for patients with hematological malignancies accompanying thrombocytopenia: A retrospective chart review

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048549

Enrollment

Registered

2022-08-02

Start date

2022-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acupuncture sessions for patients with hematological malignancies who received acupuncture during hospitalization at the Department of Hematology, Aizu Medical Center, Fukushima Medical University between May 2013 and August 2021

Exclusion criteria

Exclusion criteria: Acupuncture sessions that meet the following criteria. ? Platelet count was not measured on the same day of acupuncture. ? Platelet transfusions were performed on the same day before acupuncture. ? The time of either acupuncture or platelet transfusion was unknown. ? Non-penetrating acupuncture sessions (e.g., transcutaneous electrical acupoint stimulation) were performed.

Design outcomes

Primary

Measure	Time frame
Occurrence of grade 2 or higher bleeding according to the Common Terminology Criteria for Adverse Events version 5.0 within 24 hours from the acupuncture session or before the next session	—

Countries

Japan

Contacts

Public ContactTakumi Kayo

Aizu Medical Center, Fukushima Medical University Department of Kampo Medical Research Institute

k-takumi@fmu.ac.jp0242-75-2100

Outcome results